--- title: "Charming Medical Ltd's Lock-Up Period Will Expire on April 20th (NASDAQ:MCTA)" type: "News" locale: "en" url: "https://longbridge.com/en/news/282487616.md" description: "Charming Medical Ltd's (NASDAQ:MCTA) lock-up period will end on April 20th, allowing major shareholders and insiders to trade their shares. The company issued 1,600,000 shares during its IPO on October 21st, raising $6.4 million at an initial price of $4.00 per share. Currently, the stock has a consensus 'Sell' rating from analysts, with a recent price of $29.36. Geode Capital Management recently acquired a stake in the company, valued at approximately $316,000. Charming Medical specializes in Traditional Chinese Medicine-inspired therapies and products." datetime: "2026-04-13T05:02:07.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/282487616.md) - [en](https://longbridge.com/en/news/282487616.md) - [zh-HK](https://longbridge.com/zh-HK/news/282487616.md) --- # Charming Medical Ltd's Lock-Up Period Will Expire on April 20th (NASDAQ:MCTA) Charming Medical's (NASDAQ:MCTA - Get Free Report) lock-up period will expire on Monday, April 20th. Charming Medical had issued 1,600,000 shares in its IPO on October 21st. The total size of the offering was $6,400,000 based on an initial share price of $4.00. After the end of Charming Medical's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted. Get **Charming Medical** alerts: ## Wall Street Analyst Weigh In Separately, Weiss Ratings initiated coverage on Charming Medical in a research note on Monday, January 26th. They issued a "sell (e)" rating on the stock. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of "Sell". **Check Out Our Latest Stock Analysis on MCTA** ## Charming Medical Stock Up 6.8% Shares of Charming Medical stock opened at $29.36 on Monday. The firm's 50 day moving average price is $29.36. Charming Medical has a 12 month low of $4.30 and a 12 month high of $31.70. ## Hedge Funds Weigh In On Charming Medical A hedge fund recently bought a new stake in Charming Medical stock. Geode Capital Management LLC acquired a new stake in Charming Medical Ltd (NASDAQ:MCTA - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,752 shares of the company's stock, valued at approximately $316,000. Geode Capital Management LLC owned approximately 0.06% of Charming Medical at the end of the most recent reporting period. ## About Charming Medical (Get Free Report) We are a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. We offer a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance. Operating under the Beauty Lab Group (“Beauty Lab”) brand, our Operating Subsidiaries in Hong Kong offer a wide range of TCM-inspired beauty, wellness, and postpartum therapies and products through our four wellness centers in Hong Kong. ## See Also - Five stocks we like better than Charming Medical _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Charming Medical Right Now? Before you consider Charming Medical, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Charming Medical wasn't on the list. While Charming Medical currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [XHS.US](https://longbridge.com/en/quote/XHS.US.md) - [MCTA.US](https://longbridge.com/en/quote/MCTA.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [IHF.US](https://longbridge.com/en/quote/IHF.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) ## Related News & Research - [SBC Medical Reports Weaker Q1 2026 Results, Outlines Growth](https://longbridge.com/en/news/286407847.md) - [06:31 ETNetherton Syndrome Market Set to Expand During the Forecast Period (2026-2036) as Novel Therapies Enter Development Pipeline | DelveInsight](https://longbridge.com/en/news/286895360.md) - [Zacks Research Issues Optimistic Estimate for UNH Earnings](https://longbridge.com/en/news/286908689.md) - [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md) - [Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH](https://longbridge.com/en/news/286549656.md)